Suzanne K. Chambers

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fredrick R. Schumacher, Ali Amin Al Olama, Sonja I. Berndt et al. · Nature Genetics · 2018 · 1K citations · Full text

Life Sciences, Genetics, Oncology +14

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study

John Yaxley, Geoffrey D. Coughlin, Suzanne K. Chambers et al. · The Lancet · 2016 · 696 citations · Full text

Medicine, Surgery, Urology +17

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study

Geoffrey D. Coughlin, John Yaxley, Suzanne K. Chambers et al. · The Lancet Oncology · 2018 · 461 citations · Full text

Medicine, Surgery, Urology +16

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

Rosalind A. Eeles, Zsofia Kote‐Jarai, Ali Amin Al Olama et al. · Nature Genetics · 2009 · 424 citations

Life Sciences, Genetics, Molecular Genetics +12